col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


104 Ergebisse       Seite 1

 [1] 
Bentham Science: Current Medicinal Chemistry
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―08 In Vivo Safety Assessment of AZT-derived Organochalcogen Compounds with Promising Antiviral Effects against SARS-Cov-2 Daniela Teixeira Rodrigues, Eugênia Carla Kuhn, Jullia Dalbianco Godoy de Oliveira, Natália da Silva Silva Jardim, Daniel Balbé Nunes, Rafael Santos da Silva, et al. (+4)
2 [GO] 2025―Jan―31 Clinicopathological and in Silico Insights into Male Infertility: Agerelated Trends and Anti-sperm Antibodies Post COVID-19 Vaccination Mohammed Ahmed Alkireidmi, Mohamed Gamil Mehanna, Mirza Rafi Baig, Fahad A. Alabbasi, Naif Abdullah R. Almalki, Turky Omar Asar, et al. (+3)
3 [GO] 2025―Jan―28 COVID-19―Where Are We Now Alessia Catalano
4 [GO] 2025―Jan―14 Current Scenario in Associating Clinical COVID-19 Biomarkers for Developing Surveillance Platforms Thangavel Lakshmipriya, Subash C.B. Gopinath, Yeng Chen, Sreenivasan Sasidharan, Sreeramanan Subramaniam, Ahmad Anas Nagoor Gunny, et al. (+5)
5 [GO] 2025―Jan―08 Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins Israr Fatima, Fahad M. Alshabrmi, Faris F. Aba Alkhayl, Muhammad Qasim, Almera Shafqat, Sara Batool, et al. (+3)
6 [GO] 2025―Jan―06 Integrated in Silico and in Vitro Studies of Rutin's Potential against SARS-CoV-2 through the Inhibition of the RNA-dependent RNA Polymerase Ahmed M. Metwaly, Esmail M El-Fakharany, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Eslam B. Elkaeed, Ibrahim. H. Eissa
7 [GO] 2024―Nov―01 TLR2 Activation as a Marker of Severe COVID-19 and a Potential Therapeutic Target Xianxian Mao, Yijia Wu, Xinyi Zhang, Tian Zhou, Houda Huang, Mingui Fu, Yisong Qian
8 [GO] 2024―Okt―25 Potential Mechanisms of Covid-19 Related Nervous System Damage and Effects on Female Fertility Chen-yue Qian, Si-ning Hu, Liu Huadong, Jing-jin Liu
9 [GO] 2024―Okt―14 Identifying Mechanism of RSV for the Treatment of COVID-19 and Idiopathic Pulmonary Fibrosis via Suppressing Inflammation Response Through IL-17 Signaling Pathway from the Perspectives of in silico Study Jiahao Wang, Jiamiao Shi, Ning Jia, Qinru Sun
10 [GO] 2024―Okt―04 Integrated Exploration of Pyranocoumarin Derivatives as Synergistic Inhibitors of Dual-target for Mpro and PLpro Proteins of SARS-CoV-2 through Molecular Docking, ADMET Analysis, and Molecular Dynamics Simulation Imane Yamari, Lamiae El Bouamri, Oussama Abchir, Mohammed Bouachrine, Mhammed El Kouali, Abdelouahid Samadi, Samir Chtita
11 [GO] 2024―Okt―01 Recent Advancements in the Delivery of Therapeutic Agents Targeting RNA-dependent RNA Polymerase of SARS-CoV-2 Kalpesh Mahajan, Dipika Pawar, Sankha Bhattacharya
12 [GO] 2024―Sep―25 Exploring the Therapeutic Potential of Coumarin-thiazolotriazole Pharmacophores for SARS-CoV-2 Spike Protein through In-vitro and In-silico Evaluation Saeed Ullah, Atta Ullah, Muhammad Waqas, Sobia Ahsan Halim, Imtiaz Khan, Sadeeq ur Rehman, et al. (+6)
13 [GO] 2024―Jul―03 Safety and Efficacy of Paxlovid in Pediatric Intensive Care Unit Patients with COVID-19 Panpan Fan, Meixiu Ming, Tingyan Liu, Weiming Chen, Yixue Wang, Dan Wang, et al. (+2)
14 [GO] 2024―Jun―11 Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in SARS-CoV-2: Design Strategies and Challenges for Targeted Delivery Reza Nedaeinia, Maryam Ranjbar, Mohammad Goli, Mahmoud Etebari, Saied Safabakhsh, Hasan Bayram, et al. (+3)
15 [GO] 2024―Mai―27 Optimizing the Antimicrobial Effects by using Natural Compounds in COVID-19 Management Amin Gasmi, Asma Gasmi Benahmed, Maryam Dadar, Pavan Mujawdiya, Geir Bjørklund
16 [GO] 2024―Mai―23 The Role of Vitamins, Magnesium, and Trace Elements in COVID-19 Treatment and Post-COVID-19 Rehabilitation: An Updated Overview Geir Bjørklund, Iryna Drapak, Borys Zimenkovsky, Mariia Shanaida, Lesya Kobylinska, Olha Denefil, et al. (+6)
17 [GO] 2024―Apr―15 Research Trends in Proteomic Studies Using Serum from COVID-19 Patients: A Bibliometric Analysis Érika Alves da Fonsêca Amorim, Roberval Nascimento Moraes Neto, Ana Viviam Souza, Camila Guerra Martinez, Adrielle Zagmignan, Luís Cláudio Nascimento da Silva
18 [GO] 2024―Apr―09 Discovery of Novel Natural Inhibitors Against SARS-CoV-2 Main Protease: A Rational Approach to Antiviral Therapeutics Muhammad Waqas, Saeed Ullah, Sobia Ahsan Halim, Inam Ullah, Afnan Jan, Asaad Khalid, et al. (+3)
19 [GO] 2024―Mrz―26 Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor Yu Jiang, Yingnan Wu, Jing Wang, Yuheng Ma, Hui Yu, Zhanli Wang
20 [GO] 2024―Feb―04 Role of Ferroptosis in the Progression of COVID-19 and the Development of Long COVID Wen Zhao, Siyuan Wang, Yuxin Han, Hongkun Zhang, Jiacen Cao, Shasha Dong, et al. (+4)
21 [GO] 2024―Jan―29 Time Course of Biochemical and Metabolic Parameters During and After COVID-19 Zohreh-al-sadat Ghoreshi, Mojtaba Abbasi-jorjandi, Gholamreza Asadikaram, Mohsen Sharif-zak, Mohammad Khaksari Haddad, Ali Afgar, et al. (+3)
22 [GO] 2024―Jan―22 Atorvastatin Effect on COVID-19 Outcomes: A Propensity Score Matched Study on Hospitalized Patients Mohamad Amin Pourhoseingholi, Omid Yazdani, Mehdi Azizmohammad Looha, Seyed Amir Ahmad Safavi-Naini, Romina Esbati, Saba Ilkhani, et al. (+12)
23 [GO] 2024―Jan―22 Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review Amin Gasmi, Laura Kassym, Alain Menzel, Wajiha Anzar, Maryam Dadar, Yuliya Semenova, et al. (+6)
24 [GO] 2024―Jan―21 Natural and Synthetic Coumarins as Potential Drug Candidates Against SARS-CoV-2/CoViD-19 Iara da Silva Santos, Letícia Oliveira Magalhães, Roberta Katlen Fusco Marra, Camilo Henrique da Silva Lima, Lidilhone Hamerski, Magaly Girão Albuquerque, Bárbara Vasconcellos da Silva
25 [GO] 2023―Dez―15 Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials Behrooz Heydari, Adeleh Sahebnasagh, Mohammad Ali Omrani, Saeed Azimi, Mohammad Hossein Dehghani, Amin Salehi-Abargouei, et al. (+2)
26 [GO] 2023―Nov―29 Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-Based Fusion Inhibitors: A Review Guodong Liang, Yue Li, Ruijuan Li, Yuheng Ma, Heiya Na
27 [GO] 2023―Nov―28 SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections Mohammad A. Khanfar, Mohammad I. Saleh
28 [GO] 2023―Sep―19 How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery Mohammad Mahdi Hajihasani, Najmeh Kaffash Farkhad, Ali Mahmoudi, Amirhossein Sahebkar
29 [GO] 2023―Sep―11 Identifying luteolin as a potential drug for treating lung adenocarcinoma with COVID-19 affection based on integration analysis of pharmacology and transcriptome Ping Peng, Na Li, Ni Zhang, Xiangning Fu, Shu Peng, Yujie Zhao, Bo Ai
30 [GO] 2023―Sep―11 Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 Roberto Romeo, Laura Legnani, Maria Assunta Chiacchio, Salvatore V. Giofrè, Daniela Iannazzo
31 [GO] 2023―Jul―30 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
32 [GO] 2023―Jul―30 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
33 [GO] 2023―Jul―30 The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
34 [GO] 2023―Jul―30 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
35 [GO] 2023―Jul―18 Potential drugs in COVID-19 management Geir Bjørklund, Amin Gasmi, Sadaf Noor, Alain Menzel, Nataliia Khanyk, Yuliya Semenova, et al. (+5)
36 [GO] 2023―Jul―07 Fluvastatin: a choice for COVID-19 associated mucormycosis management Amirhossein Sahebkar, Alireza Tavakkoli, Thomas P. Johnston
37 [GO] 2023―Jun―21 Severity of COVID-19 in pregnant women: a review on the potential role of regulatory T cells Elham Abdollahi, Amirhossein Sahebkar, Nafiseh Saghafi, Mahmoud Mahmoudi, Amir Abbas Momtazi-Borojeni, Sara Mirzaeian, et al. (+2)
38 [GO] 2023―Mai―22 Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) Surya K. De
39 [GO] 2023―Mai―16 Long COVID-19 syndrome and sudden cardiac death: the phantom menace Michael Spartalis, David Zweiker, Eleftherios Spartalis, Dimitrios C. Iliopoulos, Gerasimos Siasos
40 [GO] 2023―Mai―16 The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19 Amr M. Abdelhamid, Ghada Ayeldeen, Olfat G. Shaker, Eman Amer, Mai A. Zaafan, Mohamed R. Herzalla, Mofida A. Keshk
41 [GO] 2023―Mai―05 Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human coronavirus, and Enteroviruses Surya K. De
42 [GO] 2023―Mai―04 Hydrogen sulfide: physiological roles and therapeutic implications against COVID-19 Amirhossein Sahebkar, Sajad Abolfazli, Nima Ebrahimi, Eftekhar Morabi, Mohammad Amin Asgari Yazdi, Gokhan Zengin, et al. (+2)
43 [GO] 2023―Apr―09 Perspectives and Prospects on the application of DNA Aptamer in SARS-CoV-2 Xiaoxiao Hu, Yunyi Liu, Bei Hu, Xiaming Pei, Juan Li
44 [GO] 2023―Mrz―31 SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19 Ligen Yu, Mohd Khanapi Abd Ghani, Alessio Aghemo, Debmalya Barh, Matteo Bassetti, Fausto Catena, et al. (+12)
45 [GO] 2023―Mrz―31 Traditional Chinese Medicine as the preventive and therapeutic remedy for COVID-19 Geir Bjørklund, Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Alain Menzel, Roman Lysiuk, et al. (+3)
46 [GO] 2023―Feb―24 Sleep, dietary melatonin supplementation, and COVID-19 Geir Bjørklund, Amin Gasmi, Yuliya Semenova, Sadaf Noor, Asma Gasmi Benahmed
47 [GO] 2023―Feb―23 Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity Amirhossein Sahebkar, Sepideh Karkon Shayan, Elham Nasrollahi, Yaser Bahramvand, Mahdi Zarei, Ahmadreza Atarodi, et al. (+6)
48 [GO] 2023―Feb―06 Is BMI Associated with Covid-19 Severity? A Retrospective Observational Study Marcello Candelli, Giulia Pignataro, Angela Saviano, Veronica Ojetti, Maurizio Gabrielli, Andrea Piccioni, et al. (+4)
49 [GO] 2022―Dez―07 The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19 Ilias Giannakodimos
50 [GO] 2022―Dez―07 Current Scenario and Future Prospect in the Management of COVID-19 Pobitra Borah
51 [GO] 2022―Dez―07 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis Stamatios Lampsas
52 [GO] 2022―Dez―07 The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic Rajesh Kumar
53 [GO] 2022―Dez―07 Targeting COVID-19 in Parkinsons Patients: Drugs Repurposed Firoz Anwar
54 [GO] 2022―Dez―07 COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed Mercedes Jimenez
55 [GO] 2022―Dez―07 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection Michele Costanzo
56 [GO] 2022―Dez―07 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) Shabana Bibi
57 [GO] 2022―Okt―18 Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed Firoz Anwar
58 [GO] 2022―Okt―18 SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus Michele Costanzo
59 [GO] 2022―Okt―18 In Vitro Data of Current Therapies for SARS-CoV-2 Ioanna Anastasiou
60 [GO] 2022―Okt―05 COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved Alicia B. Pomilio, Arturo A. Vitale, Alberto J. Lazarowski
61 [GO] 2022―Okt―05 Looking for SARS-CoV-2 therapeutics through computational approaches Marilisa Leone, Marian Vincenzi, Flavia Anna Mercurio
62 [GO] 2022―Sep―23 Novel Proline derivatives for Treating COVID-19 Surya K. De
63 [GO] 2022―Sep―06 Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS Seyed Mohammad Nabavi, Aysa Rezabakhsh, Seyed Fazel Nabavi, Adeleh Sahebnasagh, Ahad Shahbazi, Mojde Rahmani, et al. (+8)
64 [GO] 2022―Aug―30 Cannabinoids receptors in Covid-19: Perpetrators and victims Athanasios Alexiou, Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb
65 [GO] 2022―Jul―28 SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
66 [GO] 2022―Jul―04 Imaging markers of neurologic damage in COVID-19: a systematic review Sara Tavares Araújo, Clara Tavares Araújo, Rafael Silva e Castro, Lara Machado de Oliveira Brügger, Nathália Gualberto Souza e Silva, Debora Marques de Miranda, Ana Cristina Simões e Silva
67 [GO] 2022―Jun―28 Review on In silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2.. Yuksel Cetin, Seyma Aydinlik, Aysen Gungor, Tugce Kan, Timucin Avsar, Serdar Durdagi
68 [GO] 2022―Mai―07 Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on pandemic COVID-19 Tiziana Mundula, Edda Russo, Lavinia Curini, Francesco Giudici, Andrea Piccioni, Francesco Franceschi, Amedeo Amedei
69 [GO] 2022―Mrz―02 COVID-19 Effects on Geriatric Populationand Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccinesin the Prevention & Treatment of COVID-19 Narasimha M. Beeraka, SubbaRao V Tulimilli, M V Greeshma, Siva Dallavalasa, Yaowen Zhang, Wenjing Xiao, et al. (+6)
70 [GO] 2022―Feb―16 Perspectives and Prospects on mRNA Vaccine Development for COVID-19 Lihui Jin, Zhenyuan Han, Pengjun Zhao, Kun Sun
71 [GO] 2022―Feb―14 Aptamer-based Emerging Tools for Viral Biomarker Detection: A focus on SARS-CoV-2 Prabir Kumar Kulabhusan, Parsa Pishva, Eda Çapkın, Prajakta Tambe, Meral Yüce
72 [GO] 2021―Okt―27 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis Stamatios Lampsas, Paraskevas Tsaplaris, Panteleimon Pantelidis, Evangelos Oikonomou, Georgios Marinos, Georgios Charalambous, et al. (+9)
73 [GO] 2021―Sep―02 The impact of Vaccination worldwide on SARS-CoV-2 infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants Douglas Henrique Pereira Damasceno, Arthur Aguiar Amaral, Cecília Andrade Silva, Ana Cristina Simões e Silva
74 [GO] 2021―Aug―23 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos, Hong Yu
75 [GO] 2021―Jul―27 Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2 Luana N. O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. dos Santos, et al. (+8)
76 [GO] 2021―Jun―24 Interfering Reactive Cysteine Proteome in Covid-19 Disease Marcos Martinez-Banaclocha
77 [GO] 2021―Jun―15 Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects Davide Gentile, Vincenzo Patamia, Virginia Fuochi, Pio M. Furneri, Antonio Rescifina
78 [GO] 2021―Mai―27 COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota István Bókkon, Gábor Kapócs, András Vucskits, Attila Erdöfi-Szabó, Jan Vagedes, Felix Scholkman, Henrik Szőke
79 [GO] 2021―Mai―27 Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Knaff, Volker Mailänder, Tanja Schirmeister, Christian Kersten
80 [GO] 2021―Mai―22 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
81 [GO] 2021―Mai―10 SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies Zhao-Zhong Chong, Nizar Souayah
82 [GO] 2021―Mai―05 Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics Rahul Sharma, Dharmendra Khokhar, Bhanushree Gupta, Purnendu Saxena, Kallol Kumar Ghosh, Arvind Kumar Geda, Kamil Kuca
83 [GO] 2021―Apr―06 The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis Alice Barros Câmara, Igor Augusto Brandão
84 [GO] 2021―Mrz―30 Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2 Walter Filgueira de Azevedo Junior, Gabriela Bitencourt-Ferreira, Joana Retzke Godoy, Hilda Mayela Aran Adriano, Wallyson André dos Santos Bezerra, Alexandra Martins dos Santos Soares
85 [GO] 2021―Feb―19 Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses Sathish Veerasamy, Manivannan Chandrakumar, Malathi Balasubramaniyan, Ramesh Kumar Arumugam, Thanasekaran Pounraj
86 [GO] 2021―Feb―15 Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19 Katharina Lanza, Raphael Dias, Rafaela dos Santos Oliveira, Luís Belotto, Aline Silva Miranda, Ana Cristina Simões e Silva
87 [GO] 2021―Feb―10 Nucleoside Inhibitors of Coronaviruses Anastasia A. Zenchenko, Mikhail S. Drenichev, Sergey N. Mikhailov
88 [GO] 2021―Jan―26 Natural Products as Potential Agents Against SARS-CoV and SARS-CoV-2 Joanda Paolla Raimundo e Silva, Chonny Alexander Herrera Acevedo, Thalisson Amorim de Souza, Renata Priscila Barros de Menezes, Zoe L. Sessions, Lucas Silva Abreu, et al. (+6)
89 [GO] 2021―Jan―14 Deep learning in the quest for compound nomination for fighting COVID-19 Maria Mernea, Eliza. C. Martin, Andrei-José Petrescu, Speranta Avram
90 [GO] 2021―Jan―08 Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19 Sumera Zaib, Nehal Rana, Areeba Noor, Imtiaz Khan
91 [GO] 2020―Dez―10 The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19 Ilias Giannakodimos, Georgia-Vasiliki Gkountana, Dimosthenis Lykouras, Kiriakos Karkoulias, Sotiris Tsakas
92 [GO] 2020―Okt―28 COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed. Nuria E. Campillo, Mercedes Jimenez, Matilde Canelles
93 [GO] 2020―Okt―28 COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Cicero B. Mello
94 [GO] 2020―Okt―28 Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV) Sehrish Bano, Abdul Hameed, Mariya Al-Rashida, Shafia Iftikhar, Jamshed Iqbal
95 [GO] 2020―Okt―27 Evidence and the main adverse effects regarding drug therapies in the war against COVID-19 Mauricio Mora-Ramírez, Paulina Melgoza-Hernández, Sebastian Eduardo Toledo-Ramírez, Juan Manuel Mejía Aranguré
96 [GO] 2020―Okt―06 COVID-19 related coagulopathy: what is known up to now Ana Luísa Batista Pena, Rafael Arantes Oliveira, Renata Gomes Severo, Ana Cristina Simões e Silva
97 [GO] 2020―Sep―09 Current scenario and future prospect in the management of COVID-19 Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, et al. (+2)
98 [GO] 2020―Sep―05 Targeting COVID-19 in Parkinson’s patients: Drugs repurposed. Firoz Anwar, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo, Mohammad Amjad Kamal
99 [GO] 2020―Sep―03 Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19 Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Cristina Cerqueira Vieira, Lucas Crepaldi Carvalho Nery, Raphael Figuiredo Dias, Ana Cristina Simões e Silva
100 [GO] 2020―Jul―22 Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19 Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha AlAdhami, et al. (+6)
101 [GO] 2020―Jul―11 Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions Anil K. Sharma, Varruchi Sharma, Arun Sharma, Suresh Pallikkuth
102 [GO] 2020―Jul―02 The chronicle of COVID-19: possible strategies to curb the pandemic Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew
103 [GO] 2020―Mai―13 In vitro data of current therapies for SARS-CoV-2 Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris, Nikolaos Tentolouris
104 [GO] 2020―Apr―16 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello
 [1] 

104 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec